“������������������������������������������������r���:za33���”的搜索结果，显示 21-30 项，共有 1313 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R) MM. ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R) multiple myeloma (MM). A Study to Evaluate the Impact of Non-invasive Tests for Bladder Cancer. Rochester, Minn. Levels of bladder cancer-derived ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R FL), who have completed at least 1 prior systemic chemotherapy, immunotherapy, or chemoimmunotherapy. Two Studies for Patients With High Risk ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/R FL), who have completed at least 1 prior systemic chemotherapy, immunotherapy, or chemoimmunotherapy. Two Studies for Patients With High Risk ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... (R/M SGC). Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer, the ENHANCE Study. Rochester, Minn. The ...

8. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to describe a practical and reproducible radiographic view that can be used in the work-up of ulnocarpal impaction. Aggressive ...

9. 外科 - 临床试验- 妙佑医疗国际

   The pupose of this study is to evaluate whether or not selumetinib works just as well as the standard treatment with carboplatine/vincristine (CV) for ...

10. 外科 - 临床试验- 妙佑医疗国际

    The pupose of this study is to evaluate whether or not selumetinib works just as well as the standard treatment with carboplatine/vincristine (CV) for ...